Tumor initiation, growth and propagation are frequently accompanied by desmoplasia and the acquisition of a reactive stroma mainly comprising cancer-associated fibroblasts (CAFs). [1] [2] [3] The dynamic and reciprocal relationship between the epithelial and mesenchymal compartments of the tumor dictates almost every aspect of cancer progression, even governing the efficacy of therapy and influencing the risk of disease relapse. 4, 5 Importantly, a population of epithelial and stromal cells adjacent to the primary neoplastic lesion acquires early genetic changes but lacks histopathology, indicating that tumors prime the surrounding tissue for malignancy, an effect known as field cancerization. 6, 7 Field cancerization results in multifocal primary tumors in close proximity with a higher chance of recurrence after surgical resection of malignant tumors. 8 Although genetic and epigenetic anomalies have been well described as the driving force behind field cancerization of premalignant epithelia, 6 mediators of field cancerization by the stroma remain poorly understood.
The expansion of the cancer field requires soluble factors that promote oncogenic transformation in a non-cellautonomous manner and prime the adjacent naïve stroma to support tumor growth. Although these functions are usually ascribed to growth factors and cytokines, reactive oxygen species (ROS), which are persistently elevated in almost all cancers, have been recently identified as critical intermediates of cellular signaling. [9] [10] [11] The oxidative modification of proteins by ROS modulates intracellular signaling to influence cellular behavior and contribute to the pathophysiology of many human diseases. 12, 13 ROS are by-products of aberrant metabolism in the tumor epithelia, and their cell-autonomous mutagenic effects have been studied extensively. Much less is known about the regulation of ROS in CAFs and how ROS impact field cancerization. Notably, not all ROS are well suited for paracrine cell signaling. Superoxide anions (O2-) and hydroxyl radicals (OH•) have a very short diffusion distance because they are highly reactive, resulting in a very short half-life in the aqueous phase.
14 They also have a very low permeability coefficient for lipid bilayers. 15 In contrast, hydrogen peroxide (H 2 O 2 ) has a longer half-life, is lipid soluble and can diffuse across the cellular plasma membrane, making it an ideal field effect carcinogen. In this study, we investigated the regulation of ROS, and in particular, H 2 O 2 production, in CAFs and how this tumor stroma-mediated oxidative stress causes a premalignant field defect.
Results
Elevated ROS in the microenvironment of numerous tumor types. We first examined the oxidative status of tumor sections from patients with late stage (stage 3 to metastatic) skin squamous cell carcinoma (SCC), gastric, breast and colon cancers using the ROS-sensitive fluorescent dye CM-H 2 DCFDA. Pan-cytokeratin staining distinguished between tumor epithelia and stromal elements. All tumor sections stained positive for ROS ( Figure 1a ). SCC sections exhibited the highest intensity of ROS staining. Interestingly, ROS were not restricted to the tumor epithelia but were frequently observed in the stromal compartments of tumors. To identify the cell types responsible for elevated microenvironmental ROS, we measured extracellular H 2 O 2 in conditioned medium from various SCC lines of different aggressiveness ( Figure 1b ). HaCaT is a non-tumorigenic human keratinocyte cell line, whereas benign A-5, malignant II-4 and highly aggressive A-5RT3 are sublines of different tumorigenic potential derived from HaCaT cells. 16 HaCaT cells secreted the lowest amount of H 2 O 2 , whereas conditioned medium from A-5RT3 cells had the highest level of H 2 O 2 ( Figure 1b) . As CAFs dominate the tumor stroma and diffusible H 2 O 2 is well suited for a role in tumor stroma crosstalk, we measured the amount of H 2 O 2 in conditioned medium from CAFs explanted from four patient skin SCC biopsies alongside their paired normal fibroblasts (FIBs) (Figure 1c ). We consistently detected higher extracellular H 2 O 2 in the conditioned medium from SCC CAFs compared with FIBs.
Microenvironment oxidative stress causes a premalignant field defect. Next, we determined whether microenvironmental oxidative stress promotes premalignant development, that is, field cancerization. As the tumor promotion protocol involves a mutagen, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), we first determined the cytotoxic dose of MNNG in combination with various concentrations of H 2 17, 18 Src oxidation increases its autophosphorylation and concomitant activation. 19, 20 Indeed, an elevated level of oxidized PTEN and Src in keratinocytes treated with H 2 O 2 and MNNG was detected by PEG-switch assay, further confirmed by Oxyblot (Figure 2d (Figures 3f and g ). We observed rapid xenograft growth when cancerous A-5RT3 cells were co-injected with tFIBs compared with FIBs. Non-tumorigenic HaCaT cells also grew at an accelerated rate when co-injected with tFIBs compared with FIBs ( Figure 3f ). Immunofluorescence staining further confirmed a more proliferative and aggressive epithelial cell phenotype in the presence of tFIBs (Figure 3g ). Moreover, adoptively transferred tumors comprising A-5RT3 cells and tFIBs exhibited slower growth and less invasion in the presence of extracellular catalase compared with controls (Supplementary Figure S3C) . Taken together, our in vitro and in vivo observations suggest that ROS, specifically H 2 O 2 , induce an oxidative CAF-like state in FIBs for stromalmediated field cancerization.
Impaired TGFβ signaling reduces GPX1 expression in fibroblasts to cause a defect in ROS detoxification. Next, we investigated how extratumoral H 2 O 2 activated FIBs to participate in field cancerization. TGFβ is a potent mediator of FIB activation, which signals through the canonical Smad and non-canonical TGFβ-activated kinase-1 (TAK1) pathways. We showed that exogenous H 2 O 2 had similar activating effects on FIBs, such as elevated ROS levels, increased FAP and αSMA expression and reduced GSH:GSSG ratio (Figures 2j-l, Supplementary Figure S2F) . Next, we probed the effect of H 2 O 2 on fibroblast TGFβ signaling. A luciferase assay for TGFβ response revealed that CAFs have impaired TGFβ signaling, and FIBs became desensitized to TGFβ after 2 and 3 days of H 2 O 2 treatment (Figure 4a) . Correspondingly, Smad3 and TGFβRII mRNA expression in FIBs decreased after 2 and 3 days of H 2 O 2 treatment, and TAK1 mRNA expression decreased after 3 days of H 2 O 2 treatment (Figure 4b ). FIBs treated with CCM showed similar impairment of TGFβ signaling, which was rescued by treatment with NAC (Figures 4a and b) .
Oxidative stress also triggers NFκB activity in fibroblasts, leading to a CAF-like phenotype. 21, 22 Indeed, FIBs treated with exogenous H 2 O 2 displayed a significant increase in p65-NFκB phosphorylation after 2 and 3 days of H 2 O 2 treatment (Supplementary Figure S3D) . siRNA silencing of p65-NFκB expression in FIBs partially abrogated the H 2 O 2 -mediated suppression of Smad3, TAK1 and TGFβ mRNA and protein expression (Supplementary Figures S3E-G To determine whether FIBs with impaired TGFβ signaling promote the growth of adjacent epithelia, we performed siRNA knockdown of Smad3 (F Smad3 ), TAK1 (F TAK1 ) and TGFβRII (F TGFβRII ) in FIBs and measured mitogenic factor secretion and ROS levels. The efficiency of siRNA knockdown was validated by qPCR and immunoblotting (Figures 4c and d) . Compared with F ctrl , no differences in proliferation or apoptosis of knockdown fibroblasts were observed by FACS analysis (Supplementary Figure S4A) . We examined the secreted growth factor protein profile in CCM from these knockdown fibroblasts by ELISA. Out of a total of 76 distinct proteins screened, the expression levels of 7 secreted factors were elevated (Supplementary Figure S4B) . A comparative analysis revealed that these factors were differentially modulated by Smad3 and TAK1 in FIBs (Supplementary Figure S4B) . To further strengthen our observation, focused real-time PCR arrays comparing epithelia cocultured with CAFs and the various knockdown FIBs were performed. Notably, the expression profiles of many pro-oncogenic or tumorassociated genes in the epithelia cocultured with CAFs were also observed in the epithelia cocultured with F Smad3 , F TAK1 , F TGFβRII or treated with H 2 O 2 (Supplementary Figure S1F) . Importantly, immunoblot analysis of the epithelial layers of organotypic cocultures of keratinocytes with various knockdown fibroblasts showed the activation of the PI3K/PKB and ERK pathways associated with elevated epithelial proliferation, as indicated by PCNA (Supplementary Figure S4C) . Next, we measured ROS levels in knockdown fibroblasts. Compared with F ctrl , ROS levels were elevated in F Smad3 (8.9-fold), F TAK1 (8.4-fold) and F TGFβRII (8.2-fold) (Figures 4e and f) . We also detected a significant increase in extracellular H 2 O 2 from the knockdown fibroblasts compared with F ctrl . The concentration of extracellular H 2 O 2 was derived using a calibration curve created using known H 2 O 2 concentrations (Figure 4g ). F TGFβRII exhibited the highest amount of extracellular H 2 O 2 (Figure 4g ).
To investigate how impaired TGFβ signaling increases H 2 O 2 levels in FIBs, we examined the expression of key enzymes affecting H 2 O 2 detoxification in FIBs, namely, catalase, superoxide dismutase (SOD) and glutathione peroxidase (Gpx), using real-time PCR. No significant changes were observed in the mRNA levels of SOD1, SOD2 or catalase (Figure 4h) . Interestingly, the mRNA and protein expression levels of Gpx1 were reduced in F Smad3 , F TAK1 and F TGFβRII compared with F ctrl . H 2 O 2 treatment of FIBs also resulted in an initial spike followed by a gradual loss of Gpx1 expression, corresponding to impaired TGFβ signaling (Figure 4b) . Consistent with the qPCR data, Gpx protein expression and activity were reduced in CAFs and fibroblasts with impaired TGFβ signaling, suggesting that the GPx1 gene is regulated by Smad3-and TAK1-mediated pathways (Figures 4h and i) . These observations indicate that epithelial cells are bathed in an oxidative microenvironment supplemented with mitogenic factors secreted by stromal fibroblasts with impaired TGFβ signaling. Regulation of Gpx1 by cJUN and Smad3 in CAFs from SCCs. In silico analysis of the human GPx1 proximal promoter revealed two putative AP1-binding sites and one SMAD3-binding site (Figure 5a) . 23, 24 TAK1 is also a strong activator of cJun N-terminal kinase, which consequently activates cJUN. To determine whether GPx1 is a target gene of cJUN and Smad3, chromatin immunoprecipitation (ChIP) experiments for cJUN and Smad3 followed by re-ChIP for p300, a cJUN and Smad3 coactivator, were performed. No binding of phospho-cJUN was detected at AP1(−12), indicating that this binding site is non-functional (Supplementary Figure S5A) . There was amplification of the AP1(−262)-binding site in the human GPx1 promoter after ChIP for phospho-cJUN (Supplementary Figure S5A) and reChIP for p300 in F ctrl and F Smad3 , but not in F TAK1 and F TGFβRII (Figure 5a ). There was also amplification of the Smad3 (−172)-binding site after ChIP for phospho-Smad3 (Supplementary Figure S5A) and re-ChIP for p300 in F ctrl and F TAK1 , but not in F Smad3 and F TGFβRII (Figure 5a) . No binding was detected with preimmune serum, and there was no binding to a control sequence~2-kb upstream of the transcriptional start site. These observations indicate that the expression of the human GPx1 gene in fibroblasts is regulated by canonical and non-canonical TGFβ-mediated signaling.
To underscore the clinical relevance of TGFβ signaling in stromal fibroblasts, we examined the mRNA expression of Smad3, TAK1 and TGFβRII in laser-microdissected CAFs from human SCC and adjacent peri-normal fibroblasts (NFs) from 197 patients. During microdissection, we collected the stroma (vimentin-positive) immediately associated with tumor epithelial cells rather than stromal tissue distal to the tumor, and excluded lymphocytes and obvious vascular structures. We observed reduced expression of Smad3, TAK1 and TGFβRII, alone or in combination, in CAFs compared with NFs ( Figure 5b ). Immunoblot analysis of these TGFβ signaling mediators in CAFs and cognate NFs isolated from five resected SCC samples selected at random from the available patient sample pool showed corresponding changes (Figure 5c ). ChIP and re-ChIP experiments were also performed using NFs and CAFs (patient #5; reduced TGFβRII expression). Consistent with our earlier observations, the Smad3(-172) and AP1(-262)-binding sites of the human GPx1 promoter were occupied by Smad3:p300 and cJUN:p300 in NFs, whereas their occupancies were significantly reduced in CAFs (Figure 5d, Supplementary Figure S4B) . These results collectively indicate that impaired TGFβ signaling is a clinical feature of CAFs and is responsible for their loss of GPx1 expression and activity, which consequently leads to microenvironmental oxidative stress and field cancerization.
Discussion
CAFs are one of the most abundant stromal cells in the tumor microenvironment, facilitating the development, propagation, and invasiveness of tumors. 25 Our study showed that CAFderived ROS, specifically H 2 O 2 , induced oxidative stress in normal FIBs and trigger de novo CAF transformation in vitro and in vivo. Adoptive transfer of oxidatively tFIBs into malignant and non-tumorigenic epithelia xenografts resulted in faster-growing and more aggressive tumors, indicating exacerbated oncogenic transformation. This self-amplifying, field cancerization effect was due to impaired TGFβ signaling, leading to deficient GPx1 expression and activity in CAFs. We showed that the human GPx1 gene was regulated by TGFβ1-mediated Smad3 and TAK1/cJUN pathways in fibroblasts. Reduced expression of Smad3, TAK1 or TGFβRII was also detected in CAFs from a cohort of 197 SCC patients.
Fibroblast-specific deletion of TGFβRII in mice led to spontaneous tumors in the prostate and forestomach, which was partially attributed to the activation of paracrine HGF signaling. 26, 27 However, TGFβ is required for fibroblast activation and transition to a CAF-like state. To reconcile these paradoxical observations, we noted that TGFβ signaling operates in a negative feedback loop mediated by the inhibitory Smad, Smad7, 28, 29 which is upregulated by TGFβ via the pro-inflammatory transcription factor NFκB. 30, 31 Oxidative stress is also strongly associated with NFκB activation. 32, 33 Hence, FIBs exposed to H 2 O 2 are initially responsive to TGFβ, which facilitates their activation by tumor epithelia-and CAF-derived TGFβ. Simultaneously, H 2 O 2 triggers NFκB activation to suppress TGFβ signaling and GPx1 expression while potentiating FIB activation. In mature tumors, TGFβ is abundant and the tumor microenvironment is chronically subjected to low-grade inflammation and redox imbalance. These combined characteristics synergistically create an ecosystem that encourages the conversion of FIBs to CAFs, then renders CAFs refractory to TGFβ signaling and highly oxidative because of Gpx1 deficiency. The expression of Gpx1 is also regulated by p53, 34 and the ablation or mutation of p53 in stromal fibroblasts increased growth and metastatic spread of PC3 prostate cancer cells because of increased production of SDF-1. 35 Although the redox status of p53-deficient fibroblasts is unknown, it is conceivable that elevated H 2 O 2 may contribute to their pro-tumorigenic effect. Together with our own observation that silencing NFκB expression could prevent the H 2 O 2 -mediated impairment of TGFβ signaling in fibroblasts, these findings suggest that transcriptional control has a critical role in modulating the protumorigenic effects of CAFs.
Recent studies have revealed an important relationship between the extracellular redox state and cancer aggressiveness. 9 The activation of oncogenes in epithelial cells results in the loss of caveolin-1 and the elevated expression of lactate transporters in stromal fibroblasts. These CAF-like fibroblasts exhibited increased ROS levels and elevated glucose uptake, which complement cancer cell metabolism. 26, 36 We showed that extratumoral H 2 O 2 , either Finally, CAFs exert their proneoplastic activity by secreting mitogenic factors. Many of these factors are potential druggable targets, and it has been proposed that the inhibition of these ligand/receptor-activated signaling networks could limit neoplastic growth. We detected an increase in promitogenic factors such as HGF and FGF7 in the conditioned media harvested from keratinocytes cocultured with fibroblasts with impaired TGFβ signaling. These elevated mitogenic factors, together with extracellular H 2 O 2, promoted cancer cell proliferation, as supported by the activation of pro-oncogenic PKBα, ERK and JNK pathways in the epithelia. Our findings that the oxidative action of H 2 O 2 also enables CAF-mediated field cancerization suggest that anticancer strategies that singularly target the ligand-receptor pathways may not be effective. For example, a neutralizing antibody to HGF exhibited potent antitumor effect in the treatment of glioblastoma multiforme. 40 However, tumor growth became HGF-independent after repeated treatments. 41 Conceivably, the promiscuous nature of H 2 O 2 interactions with cellular signaling components, especially membrane-associated molecules such as EGFR and Met, renders the cells less dependent on ligand-activated pathways to promote transformation and growth. Indeed, initial efforts focused on the inhibition of PDGF with a single agent, imatinib, generated poor outcomes. 42, 43 In contrast, combination treatment with hydroxyurea and imatinib has provided very encouraging findings. 44, 45 Interestingly, hydroxyurea is a potent antioxidant that has been shown to increase the expression of Gpx1 in a p53-dependent manner, among other effects. 46 Future exploration of new multi-modal approaches that simultaneously target ligand-receptor signaling and redox-mediated pathways will offer new promising anticancer strategies.
Materials and Methods
Human tumor samples. Human SCC biopsies along with their paired perinormal tissues were provided by the National Skin Centre, Singapore. CAFs and FIBs were isolated by laser capture microdissection and subjected to protein and RNA extraction for immunoblotting and real-time PCR analyses, respectively. 47, 48 The study was approved by the National Healthcare Group Domain-Specific Review Boards (NHG-DSRB). All tumor samples were de-identified before the analyses.
In vitro tumor colony promotion protocol. Keratinocytes were seeded at a density of 1 × 10 5 per 35-mm dish containing complete OTC medium (Denova Sciences, Singapore) at day 0. On day 1, cultures were treated for 1 h with the initiating agent, MNNG, or solvent control (DMSO). The cells were washed, and the medium was replaced with complete medium for 24 h before exposure to different concentrations of H 2 O 2 . After 1 week, cells were harvested from individual dishes and passaged at a density of 1 × 10 5 per 35-mm dish in H 2 O 2 -containing medium. Concurrently, 2 × 10 4 harvested cells were embedded in 0.35% noble agar (Sigma Aldrich, St. Louis, MO, USA) and layered onto 0.7% noble agar-coated 35-mm dishes during each passage of the cells. These soft agar cultures were consistently replenished with fresh H 2 O 2 -containing medium every other day. After 1 month, viable transformed colonies were stained with 1 mg/ml thiazolyl blue tetrazolium in PBS and counted.
Cell proliferation, apoptosis assays and FACS analysis. Bromodeoxyuridine (BrdU) incorporation and total DNA content in proliferating cells were analyzed by BrdU and PI staining using the BrdU Flow kit (BD Biosciences, San Jose, CA, USA). Epithelial cells were treated for 24 h with the indicated concentrations of H 2 O 2 in serum-free medium. The cells were incubated with BrdU (40 μM) for 30 min. Apoptotic and necrotic cells were quantified using an Annexin V/ PI staining kit (BioLegend, San Diego, CA, USA) and subsequent FACS analysis.
PEG-switch assay and OxyBlot protein oxidation detection. PEGswitch assay was performed as previously described. 49 Cells treated with 100 nM H 2 O 2 or 10 ng/ml MNNG for 24 h were lysed using M-PER mammalian protein extraction reagent (Thermo Fisher Scientific, Waltham, MA, USA). Oxidized thiols were reduced using DTT and alkylated using 2 mM PEG-maleimide with 0.5% SDS for 2 h at room temperature. The alkylation reaction was quenched using 100 mM Tris-HCl buffer pH 6.8, 4% SDS, 20% glycerol, and 0.01% bromophenol blue and 100 mM maleimide and the samples were resolved by SDS-PAGE and subjected to immunoblot. Oxidatively modified PTEN was analyzed as previously described with some modifications. 17 Cells treated with 100 nM H 2 O 2 for 30 min were washed with oxygen-free ice-cold PBS containing 1 mM N-ethylmaleimide (NEM). Cells were lysed in lysis buffer (50 mM Tris, pH 6.8, 150 mM NaCl, 1 mM EDTA, 0.5% Triton X-100 and 30 mM NEM). Lysates were further clarified using aQIAshredder (Qiagen, Valencia, CA, USA). Equal amounts of proteins were mixed with NEM loading dye (50 mM Tris, pH 6.8, 10% glycerol, 2% SDS, 20 mM NEM and 0.02% bromophenol blue) and resolved by non-reducing SDS-PAGE. As a control, proteins were completely reduced by heating in SDS-loading dye containing DTT. Oxidized Src was detected as previously described. 19 The separated proteins were subjected to immunoblot analysis using antibodies against PTEN and Src. H 2 O 2 and CCM treatment of FIBs in vitro. FIBs and CAFs were seeded at a density of 1 × 10 4 per 35-mm dish in FibroGRO-LS (Millipore, Billerica, MA, USA). The 48-h CCM was collected from CAFs, sterile filtered and used immediately. CCM, with or without 100 μM N-acetylcysteine (Sigma Aldrich) pretreatment, was added to wells containing FIBs and refreshed daily over 3 days, after which FIBs were harvested for FACS analysis. Separately, FIBs were treated with 100 nM H 2 O 2 in serum-free FibroGRO-LS for 30 min twice daily with an 8-h interval between treatments for a maximum of 3 days. FIBs were harvested for FACS analysis 24 h after 1 day, 2 days and 3 days of H 2 O 2 treatment.
In vivo tumor growth and adoptive transfer of tFIBs. A total of 1 × 10 5 HaCaT or A-5RT3 cells were admixed with 2 × 10 5 CAFs and 1 × 10 5 VybrantDiO (Life Technologies, Waltham, MA, USA)-labeled FIBs in growth factor-reduced Matrigel (Corning, Tewksbury, MA, USA), with or without 500 U/ml catalase (Sigma), and implanted subcutaneously into NSG mice (Jackson Laboratory, Bar Harbor, ME, USA) (Figure 3a) . Three weeks post-implantation, tumors were excised and dissociated using the MACS tumor dissociation kit and a gentleMACS Octo Dissociator (Miltenyi Biotec, Germany). Then, the tumors were doubly stained with CellROX Deep Red (Thermo, Waltham, MA, USA) and PEconjugated anti-FAP antibody (Novus Biologicals, Littleton, CO, USA) for FACS. A total of 3 × 10 5 ROS high /FAP high tFIBs were isolated and adoptively transferred into new tumor xenografts containing either HaCaT or A-5RT3 cells. Tumor growth was monitored for 3 weeks. All animal studies were approved by the Institutional Animal Care and Use Committee of Nanyang Technological University (ARF-SBS/NIE-A0216AZ).
